Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial

Maria Jose Santa-Ana-Bayona, Camila Ponce-Acosta, Gilberto H. Acosta-Gutierrez, Pamela Morales-Alvarez, Enrique C. Guerra, Alfonso Gonzalez-Trejo, Jose Rodrigo Espinosa-Fernandez, Nestor J. Solis Flores, Hermes Ilarraza-Lomelí, Erick Alexanderson-Rosas, Yoana Leyva-López, Neftali Eduardo Antonio-Villa, Nilda Espinola-Zavaleta

Open source

DOI
10.1016/j.cct.2026.108385
Published
2026-08
Container
Contemporary Clinical Trials
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cct.2026.108385,
  title = {Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial},
  author = {Maria Jose Santa-Ana-Bayona and Camila Ponce-Acosta and Gilberto H. Acosta-Gutierrez and Pamela Morales-Alvarez and Enrique C. Guerra and Alfonso Gonzalez-Trejo and Jose Rodrigo Espinosa-Fernandez and Nestor J. Solis Flores and Hermes Ilarraza-Lomelí and Erick Alexanderson-Rosas and Yoana Leyva-López and Neftali Eduardo Antonio-Villa and Nilda Espinola-Zavaleta},
  year = {2026},
  journal = {Contemporary Clinical Trials},
  doi = {10.1016/j.cct.2026.108385},
  url = {https://doi.org/10.1016/j.cct.2026.108385}
}

RIS

TY  - JOUR
TI  - Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial
AU  - Maria Jose Santa-Ana-Bayona
AU  - Camila Ponce-Acosta
AU  - Gilberto H. Acosta-Gutierrez
AU  - Pamela Morales-Alvarez
AU  - Enrique C. Guerra
AU  - Alfonso Gonzalez-Trejo
AU  - Jose Rodrigo Espinosa-Fernandez
AU  - Nestor J. Solis Flores
AU  - Hermes Ilarraza-Lomelí
AU  - Erick Alexanderson-Rosas
AU  - Yoana Leyva-López
AU  - Neftali Eduardo Antonio-Villa
AU  - Nilda Espinola-Zavaleta
PY  - 2026
JO  - Contemporary Clinical Trials
DO  - 10.1016/j.cct.2026.108385
UR  - https://doi.org/10.1016/j.cct.2026.108385
ER  - 

APA

Santa-Ana-Bayona, M. J., Ponce-Acosta, C., Acosta-Gutierrez, G. H., Morales-Alvarez, P., Guerra, E. C., Gonzalez-Trejo, A., Espinosa-Fernandez, J. R., Flores, N. J. S., Ilarraza-Lomelí, H., Alexanderson-Rosas, E., Leyva-López, Y., Antonio-Villa, N. E., & Espinola-Zavaleta, N. (2026). Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2026.108385

Source records